PharmAla Biotech will supply the University of Texas, San Antonio with a novel LaNeo MDMA dosage form for a clinical trial, ...

Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, ...

Quick Custom Intelligence (QCI), a leading provider of data activation solutions for the gaming and hospitality industries, today announced a reactivation of its partnership with Context Networks to ...

Approximately one in eight U.S. women report experiencing postpartum depression symptoms 1 yet care pathways remain complex, leading to delayed diagnosis and treatment; Talkiatry ...

The company says it's currently the only supplier of clinical-grade MDMA for patient treatments outside of clinical trials.

PharmAla Biotech (CSE:MDMA) has been contracted as a supplier of MDMA to a clinical trial at Harvard’s Maclean Hospital ・The ...

Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...

TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (PharmAla or the Company) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

(MENAFN- GlobeNewsWire - Nasdaq) TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the“ Company ”) (CSE: MDMA) (OTC ...